摘要
目的:通过观察两组治疗前后C反应蛋白(CRP)及脂蛋白a(LPa)水平的变化,评价自拟通络饮的临床疗效。方法:本研究入选68例患者,随机分为治疗组34例,对照组34例,通过两组治疗前及治疗后第1、2、3周CRP、LPa指标的变化,并经统计学处理,观察自拟通络饮的疗效。结果:治疗组优于对照组,自拟通络饮对于CRP、LPa有明显的干预作用。
Objective：To evaluate Tongluo Decoction＇s clinical efficacy through observing the changes of the CRP and LPa levels treating before and after in two groups of cerebral infarction patients.Methods：68 patients were randomly divided into 2 groups：34 patients for treatment group,34 patients for control group.Observed the clinical effects of Tongluo Decoction by comparing the CPR and LPa levels of each group in 1,2,3 week.Results：The treatment group was better than the control group,the Tongluo Decoction had a significant intervention to the levels of CPR and LPa.
出处
《中华中医药杂志》
CAS
CSCD
北大核心
2011年第4期873-874,共2页
China Journal of Traditional Chinese Medicine and Pharmacy
